查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
到 2030 年的生物分析测试服务市场预测：按类型、分子、工作流程、治疗、最终用户和地区进行的全球分析
市场调查报告书
商品编码
1372028

到 2030 年的生物分析测试服务市场预测：按类型、分子、工作流程、治疗、最终用户和地区进行的全球分析

Bioanalytical Testing Services Market Forecasts to 2030 - Global Analysis By Type, Molecule, Workflow, Therapeutic, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，全球生物分析测试服务市场预计在预测期内将以 12.2% 的年复合成长率成长。

生物分析测试是用来测试生物和生物技术产品的分析过程的术语。分析程序在生物技术和药品生产中至关重要。药物研发、开发和商业化都涉及生物分析评估的使用。生物分析测试服务部门是更大的生命科学和医疗保健部门的一个子集，该部门使用组织、血液、尿液和其他体液来收集法规遵循、临床诊断和研究的关键资料。生物样本，例如。它对许多行业至关重要，包括生物技术、製药、环境监测、食品安全和临床研究。

印度製药协会（IPA）的报告显示，印度製药业正以7-8%的成长率成长，预计2030年年度将达到80-900亿美元。

更采用品质源自于设计 (QbD)

製药公司越来越多地利用品质源于设计 (QbD) 的概念，该概念已被 EMA 和美国FDA 等法规机构广泛接受，以提高产品品质、製造流程的稳健性和工厂生产力。看起来像这样。随着ICH Q8（R2）（药物开发）、ICH Q9（品质风险管理）和ICH Q10（药品品质系统）的发布，製药业的QbD方法与时俱进。未来年度，全球製药和生物製药企业越来越多地接受和使用 QbD 方法，预计将为全球市场的扩张做出重大贡献。

营运成本高

生物分析测试服务市场受到高营运成本的严重限制。这些成本是僱用高技能员工、维护最先进的分析设备和实施严格的品管程序所必需的。生物分析所需的昂贵设备的购买和维护成本通常很高。此外，由于需要化学、生物学和资料处理等领域的专业人员，导致人事费用高。较小的公司尤其发现很难透过提供生物分析测试服务来扩张和获利，并且需要持续投资以保持竞争力并遵守行业标准和立法。这可能会成为。

先进和多功能平台的出现

改进创新方法的先进、灵活平台的出现正在影响生物分析测试服务的成长。生物分析领域最近取得了进步，因为该领域的新方法可以解决所有可能的问题。这些因素预计将推动生物分析测试服务产业的整体成长。重要市场引进了干血斑法等尖端最尖端科技来检测药物动力学。干血斑法具有许多重要的优点，包括需要少量的处理样本、易于样本储存、减少生物危害问题以及无需采集后处理。因此，先进技术的出现预计将简化定量过程，从而增加预测期内生物分析测试服务的市场成长。

客户依赖

生物分析测试服务市场面临客户依赖的严峻挑战。如果服务公司过度依赖某些关键客户群，它们可能会在财务上变得脆弱。然而，随着主要客户迁移到其他提供者或降低其测试要求，可能会出现严重的收益短缺。为了降低这些风险，至关重要的是使您的客户群多样化并透过卓越的客户服务和附加价值服务来维持牢固的客户关係。透过客户群多元化，公司可以减少单一客户的潜在损失，并确保在竞争激烈的生物分析测试市场中实现更稳定和永续的成长。

COVID-19 的影响

COVID-19 的传播减少了工业部门的产出，并对多家全球企业产生了重大影响，导致对有效疫苗、治疗方法和其他医疗服务的需求增加。因此，疫情期间生物分析检测服务市场呈现需求成长。医疗保健提供者依靠即时护理服务和筛检技术来进行早期病毒诊断。此外，操作员还引入了减少处理时间的尖端方法和技术。基本技术包括自动化样品製备、高效液相层析和质谱。机器人和条码系统等先进技术在疫情期间已被证明是有效的。

预计样品製备部分在预测期内将是最大的

样品製备部分估计占最大份额。分析过程中一个重要的步骤是样品製备，这是生物分析测试服务市场的一个新兴领域。在测试或分析之前，必须仔细、有条理地製备生物样品。此外，样品製备技术包括样品萃取、精製、浓缩，有时还包括变性。该元素对于提高分析技术的灵敏度、特异性和精确度以及实现少量目标化合物的检测和定量至关重要。

病毒学测试领域预计在预测期内年复合成长率最高

预计病毒检测产业在预测期内将出现良好成长。生物样本中病毒的分析和检测是该市场病毒学检测的主要焦点。对于临床研究、药物开发和公共卫生至关重要。由于新的病毒性疾病和流行病带来的持续危险，对病毒检测服务的需求正在增加。本部分对于感染疾病控制和预防至关重要，因为使用多种技术来诊断和测试病毒感染，包括 PCR、血清学和次世代定序。

占比最大的地区：

由于该地区可用的设施以及美国大型大型製药企业对研发的投资不断增加，北美在预测期内获得了最大的市场占有率。此外，製药公司正在努力开发新药，目前有超过 1,100 种癌症治疗药物处于不同的临床开发阶段。由于辉瑞等主要市场参与者的存在，生物分析测试服务业务正在北美范围内扩展。

复合年复合成长率最高的地区：

预计亚太地区在预测期内将实现获利成长。在亚太地区提供生物分析测试服务的组织投资不断增加、采用这些服务的公司数量不断增加、企业和法规改革是推动亚太市场的其他因素。专注于建造生技药品管道的中国和印度小公司以及提供生物分析测试服务的公司越来越多地采用最尖端科技，例如一次性技术，正在推动市场发展。

免费客製化服务：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场公司的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的竞争关係

第5章全球生物分析测试服务市场：按类型

  • 基于细胞的检测
    • 基于细菌细胞的测定
    • 基于病毒细胞的检测
  • 病毒测试
    • 体外病毒检测
    • 体内病毒检测
    • 种特异性病毒检测
  • 最佳化方法开发
  • 血清学、免疫抗原性
  • 生物标记测试
  • 药物动力学研究
  • 生物利用度测试
  • 生物等效性研究
  • 动态测试
  • 其他类型

第6章全球生物分析测试服务市场：依分子分类

  • 低分子
  • 高分子
    • 液质联用研究
    • 免疫学测试
      • 药物动力学
      • 抗药物抗体
  • 其他分子

第7章全球生物分析测试服务市场：依工作流程

  • 样品製备
    • 液态萃取
    • 蛋白质沉淀
    • 固相萃取
  • 样品分析
    • 色谱技术
    • 连字技术
    • 配体结合测定
    • 电泳
    • 核磁共振
    • 质谱
  • 其他工作流程

第8章全球生物分析测试服务市场：按处理方式

  • 血液学
  • 神经病学
  • 代谢紊乱
  • 肿瘤学
  • 免疫学
  • 整形外科
  • 其他治疗方法

第9章全球生物分析测试服务市场：依最终用户分类

  • 製药和生物技术公司
  • 合约研究组织
  • 其他最终用户

第10章全球生物分析测试服务市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第11章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第12章公司简介

  • Syneos Health
  • Intertek Group
  • Medpace
  • PPD, Inc.
  • Eurofins Scientific
  • Laboratory Corporation of America
  • Pace Analytical Services
  • ICON plc
  • PRA Health Sciences
  • Charles River Laboratories International, Inc.
  • WuXi AppTec
  • SGS SA Toxikon, Inc.
  • IQVIA
  • Pharmaceutical Product Development
  • Frontage Labs
  • Covance Inc.
  • Altasciences
  • BioAgilytix Labs
  • Vipragen Biosciences
  • Bioneeds India Private Limited
Product Code: SMRC24084

According to Stratistics MRC, the Global Bioanalytical Testing Services Market is accounted for $5207.3 million in 2023 and is expected to reach $116.38 million by 2030 growing at a CAGR of 12.2% during the forecast period. Bioanalytical testing is the term for the analytical process used to examine biological and biotechnological products. In the production of biotechnology and pharmaceuticals, analytical procedures are essential. Drug discovery, development, and commercialization all involve the use of bio analytical evaluation. The bio analytical testing services sector is a subset of the larger life sciences and healthcare sectors that focuses on the examination and testing of biological samples, such as tissues, blood, urine, and other bodily fluids, in order to gather important data for regulatory compliance, clinical diagnosis, and research. It is crucial to many industries, including biotechnology, medicines, environmental monitoring, food safety, and clinical research.

According to a report from the Indian Pharmaceutical Alliance (IPA), the Indian pharmaceutical industry was growing at a rate of 7-8% and is estimated to register USD 80-90 billion in annual revenue by 2030.

Market Dynamics:

Driver:

Rising adoption of the quality by design approach

Pharmaceutical companies are increasingly using the Quality-by-Design (QbD) concept, which has been widely embraced by regulatory bodies like the EMA and US FDA, to improve the quality of their products, the robustness of their manufacturing processes, and the productivity of their factories. With the release of ICH Q8 (R2) (pharmaceutical development), ICH Q9 (quality risk management), and ICH Q10 (pharmaceutical quality system), the QbD method in the pharmaceutical business has evolved throughout time. In the upcoming years, it is anticipated that the growing acceptance and use of the QbD approach among pharmaceutical and biopharmaceutical operations around the world will significantly contribute to the expansion of the global market.

Restraint:

High operational costs

The market for bio analytical testing services is significantly constrained by high operational costs. These costs are required in order to hire highly skilled employees, maintain cutting-edge analytical equipment, and implement strict quality control procedures. The pricey equipment needed for bio analysis is frequently expensive to buy and keep up. Furthermore, high labour expenses are a result of the demand for specialised talent in sectors like chemistry, biology, and data processing. Smaller companies in particular may find it challenging to scale their businesses and make a profit from offering bio analytical testing services, and they may need to make continual investments to stay competitive and comply with industry standards and laws.

Opportunity:

Emergence of advanced and versatile platforms

The emergence of sophisticated and flexible platforms that improve innovative methods has had an impact on the growth of bio analytical testing services. The discipline of bio analysis has advanced recently since new approaches in the sector are capable of handling any issues that can arise. These elements are anticipated to boost the industry's overall growth for bio analytical testing services. Prominent markets are implementing cutting-edge technologies, like dry blood spot technology, to measure pharmacokinetics because it has more benefits than other traditional methods. The dry blood spot method has a number of important advantages, including the need for a small processing sample, easy sample storage, reduced biohazard concerns, the lack of post-collection processing, and many more. Therefore, the presence of advanced technologies is simplifying the quantification process and thereby expected to increase the bio analytical testing services market growth during the forecast period.

Threat:

Client dependence

The market for bio analytical testing services faces a serious challenge from client dependence. Services companies may be financially vulnerable if they rely excessively on a select group of important customers. However, a significant revenue shortfall could come from a key client shifting to another provider or reducing their testing requirements. It is crucial to reducing this danger to diversify the client base and retain solid client relationships through outstanding customer service and value-added services. By diversifying their clientele, businesses can reduce their exposure to the potential loss of a single customer and assure steadier, sustainable growth in the competitive bio analytical testing market.

COVID-19 Impact

The spread of COVID-19 has reduced the output of the industrial sectors, and as a result of its significant impact on several worldwide operations, there has been a rise in demand for effective vaccines, treatments, and other medical services. As a result, the market for bio analytical testing services saw an increase in demand during the epidemic. Healthcare providers relied on point of care services and screening techniques for early viral diagnosis in people. Additionally, the businesses have introduced cutting-edge methodologies and technology that have reduced processing time. The essential techniques include automated sample preparation, ultra-performance liquid chromatography, mass spectrometry, and others. Such advanced technologies as robotics and barcode systems have proved efficient during the pandemic.

The sample preparation segment is expected to be the largest during the forecast period

The sample preparation segment is estimated to hold the largest share. An essential step in the analysis process is sample preparation, which is an emerging area in the bio analytical testing services market. Before being tested or analysed, biological samples must be carefully and methodically prepared. Moreover, techniques for sample preparation include sample extraction, purification, concentration, and occasionally alteration. This component is essential for improving the sensitivity, specificity, and accuracy of analytical techniques and allowing the detection and quantification of small amounts of target compounds.

The virology testing segment is expected to have the highest CAGR during the forecast period

The virology testing segment is anticipated to have lucrative growth during the forecast period. The analysis and detection of viruses in biological samples is the primary focus of the virology testing component of the market. It is essential to clinical research, pharmaceutical development, and public health. The need for virology testing services has grown due to the persistent hazards posed by new viral illnesses and pandemics. This section is crucial for the management and prevention of infectious diseases because it uses a variety of techniques to diagnose and examine viral infections, including PCR, serology, and next-generation sequencing.

Region with largest share:

North America commanded the largest market share during the extrapolated period due to the facilities available across the region and increasing investment for the R&D from US pharmaceutical titans. Additionally, pharmaceuticals are working very hard to create new medicines and they have developed over 1100 oncology treatments that are in various phases of clinical development. The business for bio analytical testing services is expanding across North America because of the presence of major market players like Pfizer.

Region with highest CAGR:

Asia Pacific is expected to witness profitable growth over the projection period. A rise in investments made by organisations offering bio analytical testing services in the region, an increase in the number of companies adopting these services, and corporate and regulatory reforms are other factors driving the market in Asia Pacific. Small enterprises in China and India that are focused on building biologics pipelines, as well as an increase in the pace of adoption of cutting-edge technologies, like single-use technologies, by businesses that provide bio analytical testing services, have boosted the market.

Key players in the market

Some of the key players in the Bioanalytical Testing Services Market include: Syneos Health, Intertek Group, Med pace, PPD, Inc., Euro fins Scientific, Laboratory Corporation of America, Pace Analytical Services, ICON plc, PRA Health Sciences , Charles River Laboratories International, Inc., WuXi App Tec, SGS SA Toxikon, Inc., IQVIA, Pharmaceutical Product Development, Frontage Labs, Covance Inc., Alta sciences, BioAgilytix Labs, Vipragen Biosciences and Bio needs India Private Limited.

Key Developments:

In June 2023, ICON plc, one of the world leaders in CRO and healthcare intelligence, announced the release of its new ICON Digital Platform. The platform facilitates seamless integration of ICON site, patient, site, and sponsor services along with harmonized and customizable data delivery.

In June 2023, Syneos Health, one of the leading companies in biopharmaceutical solutions, announced a patient-centric partnership with uMotif, a clinical trial solutions organization. The collaboration is aimed at aiding the acceleration of clinical trials and introducing new therapies to patients via an end-to-end and more effective digital platform. This platform comprises robust Electronic Patient-reported Outcomes (ePRO) and Electronic Clinical Outcome Assessment (eCOA) capabilities

In May 2023, IQVIA a significant provider of advanced analytics, clinical research services, and technology solutions in the world, announced a strategic partnership RED, to battle against AIDS and the injustices that permit pandemics to thrive. This partnership supports laboratory system strengthening.

Types Covered:

  • Cell-Based Assays
  • Virology Testing
  • Method Development Optimization
  • Serology, Immunogenicity
  • Biomarker Testing
  • Pharmacokinetics Testing
  • Bioavailability Testing
  • Bioequivalence Testing
  • Pharmacodynamics Testing
  • Other Types

Molecules Covered:

  • Small Molecule
  • Large Molecule
  • Other Molecules

Workflows Covered:

  • Sample Preparation
  • Sample Analysis
  • Other Workflows

Therapeutics Covered:

  • Hematology
  • Neurology
  • Metabolic Disorders
  • Oncology
  • Immunology
  • Orthopedics
  • Other Therapeutics

End Users Covered:

  • Pharma & Biotechnology Companies
  • Contract Research Organizations
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Bioanalytical Testing Services Market, By Type

  • 5.1 Introduction
  • 5.2 Cell-Based Assays
    • 5.2.1 Bacterial Cell-Based Assays
    • 5.2.2 Viral Cell-Based Assays
  • 5.3 Virology Testing
    • 5.3.1 In Vitro Virology Testing
    • 5.3.2 In Vivo Virology Testing
    • 5.3.3 Species-Specific Viral Assays
  • 5.4 Method Development Optimization
  • 5.5 Serology, Immunogenicity
  • 5.6 Biomarker Testing
  • 5.7 Pharmacokinetics Testing
  • 5.8 Bioavailability Testing
  • 5.9 Bioequivalence Testing
  • 5.10 Pharmacodynamics Testing
  • 5.11 Other Types

6 Global Bioanalytical Testing Services Market, By Molecule

  • 6.1 Introduction
  • 6.2 Small Molecule
  • 6.3 Large Molecule
    • 6.3.1 LC-MS Studies
    • 6.3.2 Immunoassays
      • 6.3.2.1 Pharmacokinetics
      • 6.3.2.2 Anti-Drug Antibody
  • 6.4 Other Molecules

7 Global Bioanalytical Testing Services Market, By Workflow

  • 7.1 Introduction
  • 7.2 Sample Preparation
    • 7.2.1 Liquid-Liquid Extraction
    • 7.2.2 Protein Precipitation
    • 7.2.3 Solid Phase Extraction
  • 7.3 Sample Analysis
    • 7.3.1 Chromatographic Technique
    • 7.3.2 Hyphenated Technique
    • 7.3.3 Ligand Binding Assay
    • 7.3.4 Electrophoresis
    • 7.3.5 Nuclear Magnetic Resonance
    • 7.3.6 Mass Spectrometry
  • 7.4 Other Workflows

8 Global Bioanalytical Testing Services Market, By Therapeutic

  • 8.1 Introduction
  • 8.2 Hematology
  • 8.3 Neurology
  • 8.4 Metabolic Disorders
  • 8.5 Oncology
  • 8.6 Immunology
  • 8.7 Orthopedics
  • 8.8 Other Therapeutics

9 Global Bioanalytical Testing Services Market, By End User

  • 9.1 Introduction
  • 9.2 Pharma & Biotechnology Companies
  • 9.3 Contract Research Organizations
  • 9.4 Other End Users

10 Global Bioanalytical Testing Services Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Syneos Health
  • 12.2 Intertek Group
  • 12.3 Medpace
  • 12.4 PPD, Inc.
  • 12.5 Eurofins Scientific
  • 12.6 Laboratory Corporation of America
  • 12.7 Pace Analytical Services
  • 12.8 ICON plc
  • 12.9 PRA Health Sciences
  • 12.10 Charles River Laboratories International, Inc.
  • 12.11 WuXi AppTec
  • 12.12 SGS SA Toxikon, Inc.
  • 12.13 IQVIA
  • 12.14 Pharmaceutical Product Development
  • 12.15 Frontage Labs
  • 12.16 Covance Inc.
  • 12.17 Altasciences
  • 12.18 BioAgilytix Labs
  • 12.19 Vipragen Biosciences
  • 12.20 Bioneeds India Private Limited

List of Tables

  • Table 1 Global Bioanalytical Testing Services Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Bioanalytical Testing Services Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Bioanalytical Testing Services Market Outlook, By Cell-Based Assays (2021-2030) ($MN)
  • Table 4 Global Bioanalytical Testing Services Market Outlook, By Bacterial Cell-Based Assays (2021-2030) ($MN)
  • Table 5 Global Bioanalytical Testing Services Market Outlook, By Viral Cell-Based Assays (2021-2030) ($MN)
  • Table 6 Global Bioanalytical Testing Services Market Outlook, By Virology Testing (2021-2030) ($MN)
  • Table 7 Global Bioanalytical Testing Services Market Outlook, By In Vitro Virology Testing (2021-2030) ($MN)
  • Table 8 Global Bioanalytical Testing Services Market Outlook, By In Vivo Virology Testing (2021-2030) ($MN)
  • Table 9 Global Bioanalytical Testing Services Market Outlook, By Species-Specific Viral Assays (2021-2030) ($MN)
  • Table 10 Global Bioanalytical Testing Services Market Outlook, By Method Development Optimization (2021-2030) ($MN)
  • Table 11 Global Bioanalytical Testing Services Market Outlook, By Serology, Immunogenicity (2021-2030) ($MN)
  • Table 12 Global Bioanalytical Testing Services Market Outlook, By Biomarker Testing (2021-2030) ($MN)
  • Table 13 Global Bioanalytical Testing Services Market Outlook, By Pharmacokinetics Testing (2021-2030) ($MN)
  • Table 14 Global Bioanalytical Testing Services Market Outlook, By Bioavailability Testing (2021-2030) ($MN)
  • Table 15 Global Bioanalytical Testing Services Market Outlook, By Bioequivalence Testing (2021-2030) ($MN)
  • Table 16 Global Bioanalytical Testing Services Market Outlook, By Pharmacodynamics Testing (2021-2030) ($MN)
  • Table 17 Global Bioanalytical Testing Services Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 18 Global Bioanalytical Testing Services Market Outlook, By Molecule (2021-2030) ($MN)
  • Table 19 Global Bioanalytical Testing Services Market Outlook, By Small Molecule (2021-2030) ($MN)
  • Table 20 Global Bioanalytical Testing Services Market Outlook, By Large Molecule (2021-2030) ($MN)
  • Table 21 Global Bioanalytical Testing Services Market Outlook, By LC-MS Studies (2021-2030) ($MN)
  • Table 22 Global Bioanalytical Testing Services Market Outlook, By Immunoassays (2021-2030) ($MN)
  • Table 23 Global Bioanalytical Testing Services Market Outlook, By Other Molecules (2021-2030) ($MN)
  • Table 24 Global Bioanalytical Testing Services Market Outlook, By Workflow (2021-2030) ($MN)
  • Table 25 Global Bioanalytical Testing Services Market Outlook, By Sample Preparation (2021-2030) ($MN)
  • Table 26 Global Bioanalytical Testing Services Market Outlook, By Liquid-Liquid Extraction (2021-2030) ($MN)
  • Table 27 Global Bioanalytical Testing Services Market Outlook, By Protein Precipitation (2021-2030) ($MN)
  • Table 28 Global Bioanalytical Testing Services Market Outlook, By Solid Phase Extraction (2021-2030) ($MN)
  • Table 29 Global Bioanalytical Testing Services Market Outlook, By Sample Analysis (2021-2030) ($MN)
  • Table 30 Global Bioanalytical Testing Services Market Outlook, By Chromatographic Technique (2021-2030) ($MN)
  • Table 31 Global Bioanalytical Testing Services Market Outlook, By Hyphenated Technique (2021-2030) ($MN)
  • Table 32 Global Bioanalytical Testing Services Market Outlook, By Ligand Binding Assay (2021-2030) ($MN)
  • Table 33 Global Bioanalytical Testing Services Market Outlook, By Electrophoresis (2021-2030) ($MN)
  • Table 34 Global Bioanalytical Testing Services Market Outlook, By Nuclear Magnetic Resonance (2021-2030) ($MN)
  • Table 35 Global Bioanalytical Testing Services Market Outlook, By Mass Spectrometry (2021-2030) ($MN)
  • Table 36 Global Bioanalytical Testing Services Market Outlook, By Other Workflows (2021-2030) ($MN)
  • Table 37 Global Bioanalytical Testing Services Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 38 Global Bioanalytical Testing Services Market Outlook, By Hematology (2021-2030) ($MN)
  • Table 39 Global Bioanalytical Testing Services Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 40 Global Bioanalytical Testing Services Market Outlook, By Metabolic Disorders (2021-2030) ($MN)
  • Table 41 Global Bioanalytical Testing Services Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 42 Global Bioanalytical Testing Services Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 43 Global Bioanalytical Testing Services Market Outlook, By Orthopedics (2021-2030) ($MN)
  • Table 44 Global Bioanalytical Testing Services Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 45 Global Bioanalytical Testing Services Market Outlook, By End User (2021-2030) ($MN)
  • Table 46 Global Bioanalytical Testing Services Market Outlook, By Pharma & Biotechnology Companies (2021-2030) ($MN)
  • Table 47 Global Bioanalytical Testing Services Market Outlook, By Contract Research Organizations (2021-2030) ($MN)
  • Table 48 Global Bioanalytical Testing Services Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.